Tag: Espervita Therapeutics

Espervita’s EVT0185 Shows Dramatic Tumor Reduction and Immune Activation in Preclinical MASH-Driven Hepatocellular Carcinoma

ANN ARBOR, Mich., July 30, 2025 /PRNewswire/ -- Espervita Therapeutics, a biotechnology company developing targeted metabolic reprogramming therapies, announced the publication in Nature featuring groundbreaking...

- A word from our sponsors -

Newsletter Signup

Name(Required)

First Last

Email(Required)

Enter Email Confirm Email

CAPTCHA

Privacy(Required)

I agree with the storage and handling of my data by this website. - Privacy Policy *

Phone

This field is for validation purposes and should be left unchanged.

HomeTagsEspervita Therapeutics

PMI Calls for Ongoing G2G Dialogues with Source and Transit Countries to Combat Illicit Tobacco Trade

Heilind Electronics Announces Retirement of Asia President William Sim and Appointment of Charles Tan as Successor

The Government of Odisha and the Singapore-headquartered Global Finance & Technology Network (GFTN) partner to develop an Integrated Global Financial Technology Capability Hub in...

Tag: Espervita Therapeutics

Espervita’s EVT0185 Shows Dramatic Tumor Reduction and Immune Activation in Preclinical MASH-Driven Hepatocellular Carcinoma

Newsletter Signup

Explore

Press Releases

News & Opinion

Living

Others

Follow us